Donald Casey - DENTSPLY INTL Chief Executive Officer, Director
| DY2 Stock | EUR 18.18 0.32 1.73% |
CEO
Mr. Donald M. Casey was appointed Chief Executive Officer, Director of the Company effective February 12, 2018. Mr. Casey served from 2012 through 2018 as the Chief Executive Officer of the Medical Segment of Cardinal Health, a manufacturer and provider of medical products and supply chain services. From 2010 to 2012, Mr. Casey served as Chief Executive Officer of the Gary and Mary West Wireless Health Institute, a nonprofit research organization focused on lowering the cost of health care through novel technology solutions. Prior to that, Mr. Casey served from 2007 to 2010 as Worldwide Chairman for Johnson Johnsons Comprehensive Care group and as a member of the Executive Committee. Prior to that, from 2003 to 2006, Mr. Casey served as Company Group Chairman with Vistakon, a division of Johnson Johnson Vision Care, Inc., and from 1985 to 2003, Mr. Casey held various executive positions throughout Johnson Johnsons consumer, pharmaceutical and medical device franchises. Mr. Casey also served as a director of West Corporation from 2015 to 2017. since 2018.
| Age | 59 |
| Tenure | 6 years |
Donald Casey Latest Insider Activity
Tracking and analyzing the buying and selling activities of Donald Casey against DENTSPLY INTL stock is an integral part of due diligence when investing in DENTSPLY INTL. Donald Casey insider activity provides valuable insight into whether DENTSPLY INTL is net buyers or sellers over its current business cycle. Note, DENTSPLY INTL insiders must abide by specific rules, including filing SEC forms every time they buy or sell DENTSPLY INTL'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Donald Casey over six months ago Disposition of 4615 shares by Donald Casey of Anywhere Real at 5.82 subject to Rule 16b-3 |
DENTSPLY INTL Leadership Team
Elected by the shareholders, the DENTSPLY INTL's board of directors comprises two types of representatives: DENTSPLY INTL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DENTSPLY. The board's role is to monitor DENTSPLY INTL's management team and ensure that shareholders' interests are well served. DENTSPLY INTL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DENTSPLY INTL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Donald Casey, Chief Executive Officer, Director | ||
| Willie Deese, Independent Director | ||
| Daniel Key, Senior Vice President Chief Supply Chain Officer | ||
| Janet Vergis, Independent Director | ||
| Walter Petersohn, Senior Vice President Chief Commercial Officer | ||
| Matthew Coggin, Senior Vice President Business Development and Strategy Officer | ||
| Keith Ebling, Executive Vice President General Counsel, Secretary | ||
| Lisa Yankie, Senior Vice President Chief Human Resources Officer and Communications | ||
| Michael Alfano, Independent Director | ||
| Clyde Hosein, Director | ||
| Francis Lunger, Independent Director | ||
| Jorge Gomez, Chief Financial Officer, Executive Vice President | ||
| Chidam Chidambaram, Senior Vice President Chief Digital Officer | ||
| Cord Staehler, Senior Vice President, Chief Technology Officer | ||
| Ranjit Chadha, Chief Accounting Officer, Principal Accounting Officer | ||
| Harry Kraemer, Independent Director | ||
| Betsy Holden, Independent Director | ||
| Arthur Kowaloff, Independent Director | ||
| Leslie Varon, Independent Director | ||
| Eric Brandt, Non-Executive Independent Chairman of the Board | ||
| Gregory Lucier, Independent Director |
DENTSPLY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DENTSPLY INTL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 7.79 B | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 1.67 X | |||
| Revenue | 4.25 B | |||
| EBITDA | 960 M | |||
| Net Income | 421 M | |||
| Total Debt | 1.91 B | |||
| Cash Flow From Operations | 657 M | |||
| Price To Earnings To Growth | 1.64 X | |||
| Number Of Employees | 43 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DENTSPLY Stock
DENTSPLY INTL financial ratios help investors to determine whether DENTSPLY Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DENTSPLY with respect to the benefits of owning DENTSPLY INTL security.